AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you.
2 employees · est. 2003 · Wien, Austria
Passage Bio
Our mission is to improve the lives of patients with neurodegenerative diseases
43 employees · est. 2017 · Philadelphia, United States
AFFiRiS AG is the older company (2003 vs 2017); Passage Bio is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | AFFiRiS AG | Passage Bio |
|---|---|---|
| Founded | ||
| Founded | 2003 older | 2017 |
| Headquarters | ||
| Headquarters | Wien, Austria | Philadelphia, United States |
| Employees | ||
| Employees | 2 | 43 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $47.00M | $379.50M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Development of genetic medicines, Clinical trials for CNS disorders, Gene therapy solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with neurodegenerative diseases, Healthcare professionals specializing in CNS disorders, Biotech and pharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Huntington's Disease, Clinical-stage Biotechnology, SAIT, AFFITOME Technology, Peptide Vaccines, Vienna, Austria, Clinical Trials, Monoclonal Antibody | Neurodegenerative Diseases, Genetic Medicines, Clinical Stage, One-time Therapies, Lysosomal Function Restoration, Progranulin Elevation, AAV-delivered Therapeutics, Monogenic CNS Diseases, Gene Therapy, Frontotemporal Dementia, Research Collaboration, Preclinical Work, Clinical Development, Regulatory Affairs, Patient Advocacy Outreach |
| Website | ||
| Website | affiris.com | passagebio.com |
About AFFiRiS AG
AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you," encapsulates their mission to challenge established treatment options for neurode...
About Passage Bio
Passage Bio, founded in 2017 and headquartered in the United States, is a clinical stage genetic medicines company dedicated to improving the lives of patients with neurodegenerative diseases. The company operates within the Biotechnology, Health Care, and Health and Wellness industries. Their miss...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AFFiRiS AG and Passage Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AFFiRiS AG and Passage Bio — by email.
Frequently Asked Questions
Compare AFFiRiS AG with someone else
Start typing a company name or domain.